ESR1 and cancer: According to the guidelines of the American Society of Clinical Oncology (ASCO) 2010, the positive status of ER or PgR, which is defined as the presence of at least 1% stained cancer nuclei of ER or PgR, is an indication for subsequent endocrine treatment [7].